Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study.

Kang ChenLi ChenZhongyan ShanGuixia WangShen QuGui-Jun Qin Xue-Feng YuWeiquan XinTsung-Han Hsieh Yi-Ming Mu

Published in: Diabetes, obesity & metabolism (2023)

Beinaglutide combined with lifestyle intervention resulted in significant and clinically meaningful weight reduction with good tolerance in non-diabetic Chinese individuals with overweight or obesity.

Keyphrases

weight loss
weight gain
double blind
body mass index
physical activity
randomized controlled trial
type diabetes
open label
placebo controlled
insulin resistance
clinical trial
phase iii
cardiovascular disease
study protocol
body weight